Literature DB >> 12021783

Role for DNA methylation in the control of cell type specific maspin expression.

Bernard W Futscher1, Marc M Oshiro, Ryan J Wozniak, Nicholas Holtan, Christin L Hanigan, Hong Duan, Frederick E Domann.   

Abstract

The nucleotide 5-methylcytosine is involved in processes crucial in mammalian development, such as X-chromosome inactivation and gene imprinting. In addition, cytosine methylation has long been speculated to be involved in the establishment and maintenance of cell type specific expression of developmentally regulated genes; however, it has been difficult to identify clear examples of such genes, particularly in humans. Here we provide evidence that cytosine methylation of the maspin gene (SERPINB5) promoter controls, in part, normal cell type specific SERPINB5 expression. In normal cells expressing SERPINB5, the SERPINB5 promoter is unmethylated and the promoter region has acetylated histones and an accessible chromatin structure. By contrast, normal cells that do not express SERPINB5 have a completely methylated SERPINB5 promoter with hypoacetylated histones, an inaccessible chromatin structure and a transcriptional repression that is relieved by inhibition of DNA methylation. These findings indicate that cytosine methylation is important in the establishment and maintenance of cell type restricted gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021783     DOI: 10.1038/ng886

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  118 in total

1.  Non-methylated Genomic Sites Coincidence Cloning (NGSCC): an approach to large scale analysis of hypomethylated CpG patterns at predetermined genomic loci.

Authors:  T Azhikina; I Gainetdinov; Yu Skvortsova; A Batrak; N Dmitrieva; E Sverdlov
Journal:  Mol Genet Genomics       Date:  2003-12-10       Impact factor: 3.291

2.  Fidelity of the methylation pattern and its variation in the genome.

Authors:  Toshikazu Ushijima; Naoko Watanabe; Eriko Okochi; Atsushi Kaneda; Takashi Sugimura; Kazuaki Miyamoto
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

Review 3.  Flipping the epigenetic switch.

Authors:  Frederick E Domann; Bernard W Futscher
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

4.  Tissue-specific and imprinted epigenetic modifications of the human NDN gene.

Authors:  Jason C Y Lau; Meredith L Hanel; Rachel Wevrick
Journal:  Nucleic Acids Res       Date:  2004-06-24       Impact factor: 16.971

5.  Aberrant methylation of the maspin promoter is an early event in human breast cancer.

Authors:  Bernard W Futscher; Megan M O'Meara; Christina J Kim; Margaret A Rennels; Di Lu; Lynn M Gruman; Richard E B Seftor; Mary J C Hendrix; Frederick E Domann
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

6.  Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells.

Authors:  Naka Hattori; Tetsuya Abe; Naoko Hattori; Masako Suzuki; Tomoki Matsuyama; Shigeo Yoshida; En Li; Kunio Shiota
Journal:  Genome Res       Date:  2004-08-12       Impact factor: 9.043

7.  Promoter methylation confers kidney-specific expression of the Klotho gene.

Authors:  Masahiro Azuma; Daisuke Koyama; Jiro Kikuchi; Hiromichi Yoshizawa; Dissayabutra Thasinas; Kazuhiro Shiizaki; Makoto Kuro-o; Yusuke Furukawa; Eiji Kusano
Journal:  FASEB J       Date:  2012-07-10       Impact factor: 5.191

Review 8.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

9.  Epigenetic changes through DNA methylation contribute to uterine stromal cell decidualization.

Authors:  Fei Gao; Xinghong Ma; Allison Rusie; Jennifer Hemingway; Alicia B Ostmann; Daesuk Chung; Sanjoy K Das
Journal:  Endocrinology       Date:  2012-10-02       Impact factor: 4.736

Review 10.  An epigenetic perspective on the free radical theory of development.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2007-07-10       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.